A new implantable device developed by engineers at MIT can release glucagon without any external effort. The implant, which is roughly the size of a quarter and weighs less than 2 grams, could help ...

A series of symmetry-based HIV protease inhibitors was designed and synthesized. Modification of the core regiochemistry and stereochemistry significantly affected the potency, metabolic stability, ...

Our early studies demonstrated an impressive chemopreventive efficacy of dihydromethysticin (DHM), unique in kava, against tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone ...